SH2D1B anticorps (AA 65-92)

N° du produit ABIN5531084

Détail du produit anti-SH2D1B anticorps

Antigène: SH2D1B (SH2 Domain Containing 1B (SH2D1B))

Épitope: AA 65-92

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SH2D1B est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This SH2D1B antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 65-92 amino acids from the Central region of human SH2D1B.

Isotype: Ig Fraction

Information d'application

Indications d'application: For WB starting dilution is: 1:1000

For IHC-P starting dilution is: 1:50~100

For FACS starting dilution is: 1:10~50

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.35 mg/mL

Buffer: Supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur SH2D1B

Antigène: SH2D1B (SH2 Domain Containing 1B (SH2D1B))

Autre désignation: SH2D1B (SH2D1B Produits)

Synonymes: anticorps EAT2, anticorps Sh2d1b1, anticorps RGD1563935, anticorps SH2 domain containing 1B, anticorps SH2D1B, anticorps Sh2d1b

Sujet: SH2D1B plays a role in controlling signal transduction through at least four receptors, CD84, CD150, CD229 and CD244, expressed on the surface of professional antigen-presenting cells.

Poids moléculaire: 15 kDa

ID gène: 117157

UniProt: O14796

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process